Apollo Hospitals share price settles at ₹7,604.50, gains 0.06% on October 22

Key Takeaways

• Apollo Hospitals finished at ₹7,604.50, up 0.06%, after moving across a relatively wide ₹183 session range. 
• The stock recovered ₹139.50 from its displayed intraday low but remained below its 50-day, 100-day and 200-day moving averages. 
• One-month and three-month returns were -14.67% and -14.81%, while the six-month return was a milder -1.80%. 

Apollo Hospitals Enterprise share price ended October 22 at ₹7,604.50, a gain of ₹4.50 or 0.06%. The small closing change contrasted with a much wider intraday movement. The stock opened at ₹7,505 against a previous close of ₹7,600, dropped to ₹7,465 and reached a high of ₹7,648. The difference between the session high and low was ₹183. 

From the displayed low, Apollo Hospitals recovered ₹139.50 by the close. It still finished ₹43.50 below the day's high. The close was almost ₹100 above the opening level, even though the day-on-day gain was only 0.06%. Volume reached 431,865 shares. Those numbers show a session with substantially more movement inside the day than the final percentage change alone indicates. 

The closing price remained below each of the main moving averages listed by 5paisa. The 50-day DMA stood at ₹8,386.80 and the 100-day DMA at ₹8,407.70, with those two measures separated by just ₹20.90. The 200-day DMA was ₹8,176. At ₹7,604.50, the close was ₹571.50 below the 200-day average and more than ₹780 below each of the shorter displayed averages. 

Apollo Hospitals' 52-week low was ₹6,697 and its 52-week high was ₹9,071. The October 22 close stood ₹907.50 above the annual low and ₹1,466.50 below the high. This left the price between the two endpoints without being especially close to either extreme. 

The return figures showed weakness across all four displayed periods. One-month performance was -14.67%, closely matched by the three-month return of -14.81%. The six-month decline was smaller at -1.80%, while the one-year return stood at -5.09%. The near-identical one- and three-month figures were among the more unusual numerical features of the stock's October 22 profile.